Comparison of two quadruple regimens to eradication of helicobacter pylori infectio

Phase 3

• Conditions: Helicobacter pylori.; Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters; B98.0

• Registration Number: IRCT20190405043169N1
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

All patients with the age of 18 to 80 years old with proven Helicobacter pylori infection with histological sample

Exclusion Criteria

age lesser than 18 years old or more than 80 years old
taking antibiotics, NSAIDs or proton pump inhibitors over the last month
history of stomach surgery
severe impaired renal (Cr> 2 mg/dl) or hepatic function
gastric cancer
allergy to levofloxacin, amoxicillin, Metronidazole or pantoprazole
pregnant patients
chronic or severe disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of H pylori eradication. Timepoint: six weeks after the end of treatment. Method of measurement: H. pylori stool antigen test.

Secondary Outcome Measures

Name	Time	Method
Side effects. Timepoint: six weeks after treatment. Method of measurement: Questionnaire.